首页> 外文期刊>RNA >Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer
【24h】

Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer

机译:可再现的组合调控网络阐明了非小细胞肺癌中的新型致癌微RNA

获取原文
获取原文并翻译 | 示例
           

摘要

While previous studies reported aberrant expression of microRNAs (miRNAs) in non-small cell lung cancer (NSCLC), little is known about which miRNAs play central roles in NSCLC's pathogenesis and its regulatory mechanisms. To address this issue, we presented a robust computational framework that integrated matched miRNA and mRNA expression profiles in NSCLC using feed-forward loops. The network consists of miRNAs, transcription factors (TFs), and their common predicted target genes. To discern the biological meaning of their associations, we introduced the direction of regulation. A network edge validation strategy using three independent NSCLC expression profiling data sets pinpointed reproducible biological regulations. Reproducible regulation, which may reflect the true molecular interaction, has not been applied to miRNA-TF co-regulatory network analyses in cancer or other diseases yet. We revealed eight hub miRNAs that connected to a higher proportion of targets validated by independent data sets. Network analyses showed that these miRNAs might have strong oncogenic characteristics. Furthermore, we identified a novel miRNA-TF co-regulatory module that potentially suppresses the tumor suppressor activity of the TGF-β pathway by targeting a core pathway molecule (TGFBR2). Follow-up experiments showed two miRNAs (miR-9-5p and miR-130b-3p) in this module had increased expression while their target gene TGFBR2 had decreased expression in a cohort of human NSCLC. Moreover, we demonstrated these two miRNAs directly bind to the 3′ untranslated region of TGFBR2. This study enhanced our understanding of miRNA-TF co-regulatory mechanisms in NSCLC. The combined bioinformatics and validation approach we described can be applied to study other types of diseases.
机译:尽管先前的研究报道了非小细胞肺癌(NSCLC)中microRNA(miRNA)的异常表达,但对于哪些miRNA在NSCLC的发病机理及其调控机制中起着核心作用的了解却很少。为了解决这个问题,我们提出了一个强大的计算框架,该框架使用前馈环在NSCLC中整合了匹配的miRNA和mRNA表达谱。该网络由miRNA,转录因子(TF)及其常见的预测靶基因组成。为了辨别它们之间联系的生物学意义,我们介绍了调节的方向。使用三个独立的NSCLC表达谱数据集的网络边缘验证策略可精确定位可重复的生物法规。可重复的调节可能反映了真正的分子相互作用,但尚未应用于癌症或其他疾病中的miRNA-TF协同调节网络分析。我们揭示了八个中枢miRNA,它们连接到由独立数据集验证的更高比例的靶标。网络分析表明这些miRNA可能具有很强的致癌特性。此外,我们确定了一种新型的miRNA-TF协同调节模块,该模块可通过靶向核心途径分子(TGFBR2)来抑制TGF-β途径的肿瘤抑制活性。后续实验显示,在该模块中的两个miRNA(miR-9-5p和miR-130b-3p)表达增加,而其靶基因TGFBR2在人NSCLC队列中的表达减少。此外,我们证明了这两个miRNA直接与TGFBR2的3'非翻译区结合。这项研究增强了我们对NSCLC中miRNA-TF协同调节机制的了解。我们描述的生物信息学和验证相结合的方法可以用于研究其他类型的疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号